Yes, maybe so, but the discussion here was specific to AU on two standards of comparison, not to all of SGH (AU, UK, SGS). The discussion in question concerned the AU SEGMENT RESULTS and the results arising under the DEED OF CROSS GUARANTEE (a subset of the AU SEGMENT RESULTS).
My earlier post therefore concerned discussion of the AU results dissected by reference to those results captured under the DEED OF CROSS GUARANTEE and the corresponding AU segment results (including the DEED OF CRISS GUARANTEE businesses plus Nowicki (All States), STOB, Bannister Law (SG NSW PL) and Conveyancing Works). Not to all of SGH.
Normalised EPS therefore does not drill down to this level. Equally, both the CROSS GUARANTEE and the SEGMENT results do not distinguish between /remove the constituent revenue influences (ie: fees, bargain gain, change in WIP, etc).
So, yes EPS (normalised) relevant to SGH as a whole but not relevant to a specific AU contributory discussion in respect of which the CROSS GUARANTEE and the SEGMENT RESULTS provide added information /disclosure.
- Forums
- ASX - By Stock
- SGH
- All SGH questions - put here (financials ONLY)
All SGH questions - put here (financials ONLY), page-370
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online